MedTrace Logo

Antimicrobial Resistance in Cirrhotic Patients

NCT04915573 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-06-10

No results posted yet for this study

Summary

Cirrhotic patients are more vulnerable to bacterial infection, and infection is one of the most common causes of acute liver disease decompensation.

Conditions

  • Cirrhosis

Interventions

DIAGNOSTIC_TEST

Specimen

Sputum will be collected in clean disposable containers

Sponsors & Collaborators

  • Tanta University

    collaborator OTHER

  • Mansoura University

    lead OTHER

Principal Investigators

  • Noha Mansour, Ph.D · Mansoura University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-07
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04915573 on ClinicalTrials.gov